Relonchem receives marketing authorization for Ibuprofen and Paracetamol 200 mg/500 mg Film-coated Tablets

Marksans Pharma announced that its wholly owned subsidiary Relonchem has received Marketing Authorization for the product Ibuprofen and Paracetamol 200 mg/500 mg Film-coated Tablets (Bell's Healthcare Dual Action Pain Relief 200 mg/500 mg Film-coated Tablets).